HIF PH4 Antibody, mAb, Rabbit
| $210.00 | |
| A05489-50 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $210.00 | |
| A05489-50 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Specificity | This product is specific to HIF PH4 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human HIF PH4 |
| Species Reactivity | Human |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||
|
|||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Immunoprecipitate (IP) analysis using the HIF PH4 Antibody, mAb, Rabbit at 1:50 dilution. (wb at 1:1K dilution) »
| Target Background | Catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates HIF1A at 'Pro-402' and 'Pro-564'. May function as a cellular oxygen sensor and, under normoxic conditions, may target HIF through the hydroxylation for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. |
| Synonyms | EGLN4 ; HIFPH4; Hypoxia inducible factor prolyl 4 hydroxylase; P4H with transmembrane domain; P4htm; PH4; PHD4; Proline 4 hydroxylase; Prolyl hydroxlase domain containing 4; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.